Paul Tudor Jones Wave Life Sciences Ltd. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 15,202 shares of WVE stock, worth $218,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,202

Holding current value

$218,148

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $77,834 - $136,970	15,202 New	15,202 $124,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $152,172 - $251,304	36,580 New	36,580 $184,000
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $1,367 - $2,406	-382 Reduced 0.9%	42,217 $183,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $1,758 - $3,871	-553 Reduced 1.28%	42,599 $298,000
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $27,714 - $45,450	13,857 Added 47.3%	43,152 $86,000
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $3,322 - $5,448	1,058 Added 3.75%	29,295 $92,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $138,078 - $201,047	28,237 New	28,237 $138,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $260,041 - $343,806	-46,025 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $258,200 - $552,760	46,025 New	46,025 $258,000
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $377,229 - $499,734	-53,967 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $458,179 - $1.05 Million	53,967 New	53,967 $458,000
Q1 2019 May 15, 2019	SELL	$32.69 - $47.91 $321,669 - $471,434	-9,840 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $132,001 - $178,291	-3,558 Reduced 26.56%	9,840 $414,000
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $487,017 - $739,569	13,398 New	13,398 $670,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.25B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account